P360 Revenue and Competitors
Estimated Revenue & Valuation
- P360's estimated annual revenue is currently $55.1M per year.
- P360's estimated revenue per employee is $175,000
Employee Data
- P360 has 315 Employees.
- P360 grew their employee count by 24% last year.
P360's People
Name | Title | Email/Phone |
---|---|---|
1 | Founder and COO | Reveal Email/Phone |
2 | V.P. Business Development and Operations; ZING Product Owner | Reveal Email/Phone |
3 | SVP Strategy | Reveal Email/Phone |
4 | Data Scientist | Reveal Email/Phone |
5 | Director Customer Service & Product Strategy | Reveal Email/Phone |
6 | Chief Operating officer | Reveal Email/Phone |
7 | Director, Account Management | Reveal Email/Phone |
8 | Asst. Manager HR | Reveal Email/Phone |
9 | Customer Success Manager | Reveal Email/Phone |
10 | Delivery Manager | Reveal Email/Phone |
P360 Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $11.6M | 83 | 6% | N/A | N/A |
#2 | $3.9M | 35 | N/A | N/A | N/A |
#3 | $24.2M | 157 | N/A | N/A | N/A |
#4 | $614.1M | 3133 | 8% | N/A | N/A |
#5 | $55.1M | 315 | 24% | N/A | N/A |
#6 | $13.3M | 95 | -7% | N/A | N/A |
#7 | $269.3M | 1345 | -1% | $92.6M | N/A |
#8 | $889.3M | 4442 | 6% | $63M | N/A |
#9 | $7.4M | 59 | 48% | N/A | N/A |
#10 | $1.2M | 14 | 8% | N/A | N/A |
What Is P360?
P360 enables life science companies to proactively engage AI technology across all aspects of their business ? sales, clinical trials, patient journey, analytics ? even providing custom built solutions fueled by an internal team powered in the highest global technology competencies. Our company has an incredible passion for pharma business and a personal standard of unparalleled service, which is why we have transformed our company to an elevated level. You will notice many changes and inherent simplicities, aligned with the dynamic future of responsive computing, yet simple and powerful - down to our new name ?P360?. This is the culmination of an ongoing momentum of change - to create a new paradigm of commercialization and bring sophisticated simplicity to your business. From the top down our culture exudes this passion, evident in the walk and talk of our CEO, Anupam Nandwana: ?We?d like to introduce you to P360 ? an amazing overhaul of Prescriber360 ? better aligning with the dynamics of data transformation and further disrupting the status-quo of commercial business in life sciences. We are proud of our metamorphic business modalities - from our newly launched Swittons ?Virtual Rep? device to bridge communication between pharma and physicians (an industry first!), to our Data360 enablement solution, to custom enterprise & cloud solutions, and more ? business with us elevates all aspects of your business. We are proud to transform our own company, to further transform yours ? providing powered disruption and data transformation of the future. And with the power of Microsoft platforms at our foundation, everything is possible.? ? Anupam Nandwana, CEO When you partner with P360, your organization accesses a vast array of cutting-edge, business-enhancing solutions and services that drive your capabilities far beyond your competitors in the marketplace. Powered possibilities.
keywords:N/AN/A
Total Funding
315
Number of Employees
$55.1M
Revenue (est)
24%
Employee Growth %
N/A
Valuation
N/A
Accelerator
P360 News
There is simply no denying the appeal of this 2022 Land Rover Discovery P360 R-Dynamic HSE. Especially cloaked in Eiger Grey like our tester...
With the P360 option checked, power comes from a turbocharged, inline six-cylinder engine that receives additional oomph from a 48-volt,...
Built with the latest high-performance 12th Gen Intel processors and support for up to NVIDIA RTX A5000 graphics, the ThinkStation P360...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.5M | 319 | 9% | N/A |
#2 | $87.9M | 335 | 4% | N/A |
#3 | $7.5M | 341 | 8% | N/A |
#4 | $82.6M | 367 | 27% | N/A |
#5 | $60M | 387 | 39% | N/A |